Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Animalcare GroupSTU:WQ7 77 Days Payable is 120.09 as of Dec. 2025, which is 0% above its 10-year median of 119.69. GuruFocus rates STU:WQ7 with a GF Score™ of 77/100 and a GF Value™ of €2.85 (Fairly Valued). The stock has 7 warning signs investors should review. Among 925 Drug Manufacturers companies, Animalcare Group ranks better than 65.41% on this metric.
The historical rank and industry rank for Animalcare Group's Days Payable or its related term are showing as below:
STU:WQ7'
s Days Payable Range Over the Past 10 Years
Min: 66.69 Med: 119.69 Max: 156.96
Current: 119.46
During the past 13 years, Animalcare Group's highest Days Payable was 156.96. The lowest was 66.69. And the median was 119.69.
STU:WQ7's Days Payable is ranked better than 65.41% of 925
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs STU:WQ7: 119.46
Animalcare Group's Days Payable
declined
from Dec. 2024 (131.41) to Dec. 2025 (120.09).
It may suggest that Animalcare Groupaccelerated paying its suppliers.
Animalcare Group Days Payable Related Terms
Animalcare Group Days Payable Historical Data
* Premium members only.
The historical data trend for Animalcare Group's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:WQ7 vs ZTS, UTHR, VTRS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Animalcare Group's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Animalcare Group Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Animalcare Group's Days Payable distribution charts can be found below:
* The bar in red indicates where Animalcare Group's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Animalcare Group's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Animalcare Group (STU:WQ7) has a Days Payable of 120.09 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Animalcare Group and its competitors. This is near median its historical median of 119.69. Over the past decade, Animalcare Group's Days Payable has ranged from 66.69 to 156.96. According to the industry distribution chart, Animalcare Group ranks #320 out of 925 companies in the Drug Manufacturers industry, placing it in the top 34.6%.
Is Animalcare Group's Days Payable too high?
Animalcare Group's current Days Payable of 120.09 is near median its 10-year median of 119.69. Over the past 10 years, this metric has ranged from a low of 66.69 to a high of 156.96. The Drug Manufacturers industry median Days Payable is 90.38. Animalcare Group's value of 120.09 is 32.9% above this industry median. Based on the distribution chart, Animalcare Group ranks #320 out of 925 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Animalcare Group has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Animalcare Group's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Animalcare Group ranks #320 out of 925 companies for Days Payable. This puts Animalcare Group in the upper half of its industry. The industry median Days Payable is 90.38. Animalcare Group's value of 120.09 is 32.9% above this benchmark. Historically, Animalcare Group's own Days Payable has ranged from 66.69 to 156.96 over the past decade. While the company's 10-year median is 119.69 vs. the industry median of 90.38, Animalcare Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 925 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Animalcare Group's current Days Payable of 120.09 is 32.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Animalcare Group and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Animalcare Group's current Days Payable is 120.09, which is near median its own 10-year median of 119.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Animalcare Group stock overvalued right now?
Based on GuruFocus' analysis, Animalcare Group (STU:WQ7) is currently considered Fairly Valued. The stock's GF Value™ is €2.85, compared to a current price of €3.00 — trading 5.3% above its estimated fair value. The current Days Payable is 120.09, which is near median its 10-year median of 119.69 and 32.9% above the Drug Manufacturers industry median of 90.38. Animalcare Group's overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Animalcare Group (STU:WQ7), the current Days Payable is 120.09 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Animalcare Group (STU:WQ7) Overvalued in 2026?
Based on GuruFocus' analysis, Animalcare Group stock appears to be overvalued.
The current stock price of €3.00 is trading 5.3% above its estimated GF Value™ of €2.85.
GuruFocus considers Animalcare Group to be Fairly Valued.
Key valuation signals for STU:WQ7:
Days Payable: 120.09 (near median its 10-year median of 119.69)
GF Value™: €2.85 vs. price of €3.00 (5.3% above fair value)
Industry Position: 32.9% above the Drug Manufacturers median (#320 of 925)
No single metric tells the full story. See the STU:WQ7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Animalcare Group PLC is active in the healthcare division in the United Kingdom. It is a generic veterinary medicines company. The company mainly caters to veterinary professionals in the treatment of companion animals through a product line comprised of licensed veterinary medicines and companion animal identification products and services. The company operates in Animalcare Europe and Randlab segment. The company derives maximum revenue from the Animalcare Europe segment engaged in development and sale of veterinary pharmaceutical products in Europe and the European International Partners network. Geographically, the company derives maximum revenue from Europe region, followed by Asia-Pacific and other regions.
77GF Score
Get the complete analysis for STU:WQ7
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:WQ7 has been successfully added to your 
